EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Demonstrating service delivery models for effective initiation and retention on pre-exposure prophylaxis (PrEP) among female bar workers in Dar es Salaam, Tanzania: A double randomized intervention study protocol

Joy J Chebet, Winfrida Onesmo Akyoo iD, Hannah Goymann, Guy Harling, Dale A Barnhart, Idda H Mosha, Doreen Donald Kamori, Monica Gandhi, Theodora Mbunda, Judith Kipeleka, David Sando, Donna Spiegelman und 2 weitere

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0304077 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift PLOS ONE, 2024. Verfasst von Joy J Chebet und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Promotion Sciences, Mel and Enid Zuckerman College of Public Health, The University of Arizona, Tucson, Arizona, United States o…. Hauptthemen laut MEDLINE: Pre-Exposure Prophylaxis, HIV Infections, Anti-HIV Agents, Sex Workers. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIEHS NIH HHS, Wellcome Trust and Royal Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pre-Exposure Prophylaxis (PrEP) has demonstrated efficacy in preventing HIV infection. Female Bar Workers (FBWs) often act as informal sex workers, placing them at risk of HIV infection. Despite expressing interest in PrEP, FBWs face barriers to accessing public-sector clinics where PrEP is delivered. We developed a study to compare the effectiveness of workplace-based PrEP provision to standard-of-care facility-based provision for PrEP initiation, retention and adherence among FBWs.

Methods

In this double-randomized intervention study, FBWs aged 15 years and above will be screened, consented and initiated on PrEP (emtricitabine/tenofovir disoproxil), and followed for six months. Participants will be randomized at the bar level and offered PrEP at their workplace or at a health facility. Those who are initiated will be independently individually randomized to either receive or not receive an omni-channel PrEP champion intervention (support from an experienced PrEP user) to improve PrEP adherence. We expect to screen 1,205 FBWs to enroll at least 160 HIV negative women in the study. Follow-up visits will be scheduled monthly. HIV testing will be performed at baseline, month 1, 4 and 6; and TDF testing at months 2 and 6. Primary outcomes for this trial are: (1) initiation on PrEP (proportion of those offered PrEP directly observed to initiate PrEP); and (2) adherence to PrEP (detectable urine TDF drug level at 6-months post-enrollment). The primary outcomes will be analyzed using Intention-to-Treat (ITT) analyses.

Discussion

Using a randomized trial design, we will evaluate two interventions aiming to reduce barriers to uptake and retention on PrEP among FBWs, a vulnerable population at risk of HIV acquisition and onward transmission. If these interventions prove effective in promoting PrEP among FBWs, they could assist in abating the HIV epidemic in Africa.

Trial registration

Registered with German Clinical Trials Register ( www.drks.de ) on 29 April 2020; Registration number DRKS00018101 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-Exposure ProphylaxisHIV InfectionsAnti-HIV AgentsSex WorkersHumansFemaleTanzaniaAdultMedication AdherenceAdolescentYoung AdultTenofovirRandomized Controlled Trials as Topic

Substanzen

Anti-HIV AgentsTenofovir

Autor:innen und Institutionen

  • Department of Health Promotion Sciences, Mel and Enid Zuckerman College of Public Health, The University of Arizona, Tucson, Arizona, United States of America.
  • Department of Behavioural Sciences, School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, Dar-es-Salaam, Tanzania.
  • Heidelberg Institute of Global Health, Medical Faculty and University Hospital, Heidelberg University, Heidelberg, Germany.
  • Institute for Global Health, University College London, London, United Kingdom.
  • Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America.
  • Africa Health Research Institute, KwaZulu-Natal, South Africa.

ORCID-Profile: Winfrida Onesmo Akyoo

Förderung

  • NIAID NIH HHS
  • NIEHS NIH HHS
  • Wellcome Trust and Royal Society
  • NIH

Zitieren

APA

Chebet, J. J., Akyoo, W. O., Goymann, H., Harling, G., Barnhart, D. A., Mosha, I. H., Kamori, D. D., Gandhi, M., Mbunda, T., Kipeleka, J., Sando, D., Spiegelman, D., Mpembeni, R., & Bärnighausen, T. (2024). Demonstrating service delivery models for effective initiation and retention on pre-exposure prophylaxis (PrEP) among female bar workers in Dar es Salaam, Tanzania: A double randomized intervention study protocol. PLOS ONE. https://doi.org/10.1371/journal.pone.0304077

Vancouver

Chebet JJ, Akyoo WO, Goymann H, Harling G, Barnhart DA, Mosha IH, et al. Demonstrating service delivery models for effective initiation and retention on pre-exposure prophylaxis (PrEP) among female bar workers in Dar es Salaam, Tanzania: A double randomized intervention study protocol. PLOS ONE. 2024. doi:10.1371/journal.pone.0304077

BibTeX
@article{Chebet2024,
  author = {Chebet, Joy J and Akyoo, Winfrida Onesmo and Goymann, Hannah and Harling, Guy and Barnhart, Dale A and Mosha, Idda H and Kamori, Doreen Donald and Gandhi, Monica and Mbunda, Theodora and Kipeleka, Judith and Sando, David and Spiegelman, Donna and Mpembeni, Rose and Bärnighausen, Till},
  title = {Demonstrating service delivery models for effective initiation and retention on pre-exposure prophylaxis (PrEP) among female bar workers in Dar es Salaam, Tanzania: A double randomized intervention study protocol},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0304077}
}
Kostenlos starten →